(Total Views: 558)
Posted On: 08/27/2022 2:28:48 PM
Post# of 148898
To be devil's advocate... isn't it possible the FDA just won't accept anecdotal claims mid-pandemic and insisted on data, even if only to support the anecdotal claims... BUT... Amarex made such a dog's dinner of our science they royally ****ed us and tied the FDA's hands.
I agree the FDA should have helped more as only a blind man couldn't see that Leronlimab has serious therapeutic value, but the more time passes the more I'm convinced Amarex failed 1000% across the board and boxed us in for 3 years and counting.
Mgmt is in the process of fixing the data to finally give the FDA what it wants. At that juncture, let's see what the FDA does. At minimum, holds should be lifted "overnight." Will they then assist with LH? Will they finally see its value for critical Covid?
I agree the FDA should have helped more as only a blind man couldn't see that Leronlimab has serious therapeutic value, but the more time passes the more I'm convinced Amarex failed 1000% across the board and boxed us in for 3 years and counting.
Mgmt is in the process of fixing the data to finally give the FDA what it wants. At that juncture, let's see what the FDA does. At minimum, holds should be lifted "overnight." Will they then assist with LH? Will they finally see its value for critical Covid?
(3)
(0)Scroll down for more posts ▼
